Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 known ✓ | P35372 | 5/20 | 0.43 |
| ▸ | OPRK1 known ✓ | P41145 | 4/20 | 0.43 |
| ▸ | OPRD1 known ✓ | P41143 | 2/20 | 0.43 |
| ▸ | PRCP | P42785 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | GID4 | Q8IVV7 | 1/20 | 0.37 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3247160 | 0.90 | PRCP (0.57) | PRCPOPRM1OPRK1OPRD1ALDH1A1 | |
| Cadaverine Tartrate SCHEMBL1477981 | 0.76 | PRCP (0.73) | PRCPTSHRNPSR1GAAMAPT | |
| Cadaverine Tartrate SCHEMBL1668270 | 0.76 | PRCP (0.73) | PRCPTSHRNPSR1GAAMAPT | |
| SCHEMBL27893411 | 0.74 | PRCP (0.63) | PRCPGAAMAPT | |
| SCHEMBL17104079 | 0.71 | PTGDR2 (0.55) | PRCPOPRM1OPRK1OPRD1ALDH1A1 | |
| SCHEMBL17104078 | 0.71 | PTGDR2 (0.55) | PRCPOPRM1OPRK1OPRD1ALDH1A1 | |
| Lorcaserin SCHEMBL28756457 | 0.69 | HTR2A (0.76) | — | |
| Lorcaserin SCHEMBL29544227 | 0.69 | HTR2A (0.76) | — | |
| Cadaverine Tartrate SCHEMBL5925463 | 0.69 | PRCP (0.41) | PRCPOPRM1OPRK1OPRD1ALDH1A1 | |
| Lorcaserin SCHEMBL4143777 | 0.68 | HTR2A (0.64) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6989052-B1 | Phase change ink printing process | XEROX CORPORATION (US) | 2006-01-24 | — | — | US | claimed |
| US-6989052-B1 | Phase change ink printing process | XEROX CORPORATION (US) | 2006-01-24 | — | — | US | disclosed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | disclosed |